Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo
Matt D. T. Hitchings, Otávio T. Ranzani, Murilo Dorión, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Baoqi Zeng, Le Gao, Qingxin Zhou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 236
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, et al.
PLoS Medicine (2022) Vol. 19, Iss. 5, pp. e1003991-e1003991
Open Access | Times Cited: 93
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 82
COVID‐19 in Latin America and the Caribbean: Two years of the pandemic
Alvaro Schwalb, Eleonora Armyra, Melissa Méndez‐Aranda, et al.
Journal of Internal Medicine (2022) Vol. 292, Iss. 3, pp. 409-427
Open Access | Times Cited: 52
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
Peter Schmidt, Kristin Narayan, Yong Li, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 688
Open Access | Times Cited: 24
Can a combination of vaccination and face mask wearing contain the COVID‐19 pandemic?
Harald Brüssow, Sophie Zuber
Microbial Biotechnology (2021) Vol. 15, Iss. 3, pp. 721-737
Open Access | Times Cited: 52
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 49
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
Katherine S. Lee, Ting Y. Wong, Brynnan P. Russ, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273430-e0273430
Open Access | Times Cited: 34
Real-Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis
Kai Wang, Lin Wang, Mingzhe Li, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 33
Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Zhilu Yuan, Zengyang Shao, Lijia Ma, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1994-1994
Open Access | Times Cited: 20
Double Negative Control Inference in Test-Negative Design Studies of Vaccine Effectiveness
Kendrick Qijun Li, Xu Shi, Miao Wang, et al.
Journal of the American Statistical Association (2023), pp. 1-12
Open Access | Times Cited: 18
Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants
Severino Jefferson Ribeiro da Silva, Suelen Cristina de Lima, Ronaldo Celerino da Silva, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 25
Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study
Felippe Lazar Neto, Matt D. T. Hitchings, Avnika B. Amin, et al.
The Lancet Regional Health - Americas (2024) Vol. 34, pp. 100755-100755
Open Access | Times Cited: 4
Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review
Jesse M. van den Berg, Sharon Remmelzwaal, Marieke T. Blom, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 24-24
Open Access | Times Cited: 21
Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review
Lia Reynolds, Cate Dewey, Ghaid Asfour, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 11
Computational analysis of the sequence-structure relation in SARS-CoV-2 spike protein using protein contact networks
Pietro Hiram Guzzi, Luisa Di Paola, Barbara Puccio, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster
Rafael Rahal Guaragna Machado, Erika Donizette Candido, Andressa Simões Aguiar, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 144-144
Open Access | Times Cited: 3
Mudanças no padrão de internações e óbitos por COVID-19 após substancial vacinação de idosos em Manaus, Amazonas, Brasil
Jesem Douglas Yamall Orellana, Geraldo Marcelo da Cunha, Lihsieh Marrero, et al.
Cadernos de Saúde Pública (2022) Vol. 38, Iss. 5
Open Access | Times Cited: 18
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study
Kim Bouillon, Bérangère Baricault, Jérémie Botton, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000104-e000104
Open Access | Times Cited: 18
COVID-19 Vaccine: Between Myth and Truth
Pier Paolo Piccaluga, Antonio Di Guardo, Anna Lagni, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 349-349
Open Access | Times Cited: 17
Effectiveness of Primary and Booster COVID-19 mRNA Vaccination against Omicron Variant SARS-CoV-2 Infection in People with a Prior SARS-CoV-2 Infection
Margaret L. Lind, Alexander J. Robertson, Julio Silva, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17
An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants
Muhammad Zafar Irshad Khan, Adila Nazli, Hawaa Al-furas, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top